Adult cancer pain.
作者信息
Swarm Robert, Abernethy Amy Pickar, Anghelescu Doralina L, Benedetti Costantino, Blinderman Craig D, Boston Barry, Cleeland Charles, Coyle Nessa, Deleon-Casasola Oscar A, Eilers June G, Ferrell Betty, Janjan Nora A, Karver Sloan Beth, Levy Michael H, Lynch Maureen, Moryl Natalie, Murphy Barbara A, Nesbit Suzanne A, Oakes Linda, Obbens Eugenie A, Paice Judith A, Rabow Michael W, Syrjala Karen L, Urba Susan, Weinstein Sharon M
出版信息
J Natl Compr Canc Netw. 2010 Sep;8(9):1046-86. doi: 10.6004/jnccn.2010.0076.
Abstract
摘要
相似文献
1
Adult cancer pain.成人癌症疼痛。
J Natl Compr Canc Netw. 2010 Sep;8(9):1046-86. doi: 10.6004/jnccn.2010.0076.
2
National Comprehensive Cancer network adult pain guidelines.
J Pain Palliat Care Pharmacother. 2006;20(2):94.
3
Management of cancer pain.
Clin Adv Hematol Oncol. 2012 Dec;10(12):829-31.
4
Controlling the pain of cancer.控制癌症疼痛。
Sci Am. 1996 Sep;275(3):164-5. doi: 10.1038/scientificamerican0996-164.
5
[The guideline "Pain in cancer' is there. Now we still need the implementation].
Ned Tijdschr Geneeskd. 2009 Mar 21;153(12):535-7.
6
Advances in cancer pain management in 2005.
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S126. doi: 10.1016/j.ygyno.2005.07.058.
7
Cancer pain management.
Clin Adv Hematol Oncol. 2005 Jan;3(1):30-2.
8
Chronic cancer pain. National Cancer Pain Coalition.
J Pract Nurs. 1996 Dec;46(4):13-6, 43.
9
[Treatment of cancer-related bone pain].[癌症相关骨痛的治疗]
Med Monatsschr Pharm. 2016 Jan;39(1):40-2.
10
Management of cancer pain: ESMO clinical recommendations.癌症疼痛的管理：ESMO临床建议。
Ann Oncol. 2007 Apr;18 Suppl 2:ii92-4. doi: 10.1093/annonc/mdm053.
引用本文的文献
1
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.用于选择阿片类药物治疗癌症疼痛的双单核苷酸多态性生物标志物组合
Mol Clin Oncol. 2024 Nov 29;22(2):14. doi: 10.3892/mco.2024.2809. eCollection 2025 Feb.
2
Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: Perspectives from Nepal.当前临床药师在癌症疼痛管理中作用的实践、差距和机遇：来自尼泊尔的观点。
J Oncol Pharm Pract. 2023 Dec;29(8):2049-2056. doi: 10.1177/10781552231205025. Epub 2023 Oct 17.
3
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.用于预测阿片类药物对癌症疼痛疗效的新型单核苷酸多态性生物标志物。
Oncol Lett. 2023 Jul 4;26(2):355. doi: 10.3892/ol.2023.13941. eCollection 2023 Aug.
4
Psychological Evaluation of Patients With Cancer Presenting to the Emergency Department With Pain: Independent Predictors of Worse Pain Severity, Interference, and Higher Hourly Opioid Administration.急诊科以疼痛为主诉的癌症患者的心理评估：更严重疼痛严重程度、干扰和更高每小时阿片类药物给药的独立预测因素。
JCO Oncol Pract. 2022 Oct;18(10):e1648-e1660. doi: 10.1200/OP.22.00142. Epub 2022 Aug 22.
5
Pain management practices for outpatients with breast cancer.乳腺癌门诊患者的疼痛管理实践
Explor Res Clin Soc Pharm. 2022 Jul 4;6:100155. doi: 10.1016/j.rcsop.2022.100155. eCollection 2022 Jun.
6
Lidocaine Infusion for the Management of Postoperative Pain and Delirium (LIMPP): protocol for a randomised control trial.利多卡因输注治疗术后疼痛和谵妄（LIMPP）：一项随机对照试验的方案。
BMJ Open. 2022 Jun 6;12(6):e059416. doi: 10.1136/bmjopen-2021-059416.
7
Comparative Analysis of the Efficacy and Safety of Different Traditional Chinese Medicine Injections in the Treatment of Cancer-Related Pain: A Bayesian Network Meta-Analysis.不同中药注射剂治疗癌痛的疗效与安全性比较分析：一项贝叶斯网络Meta分析
Front Pharmacol. 2022 Feb 7;12:803676. doi: 10.3389/fphar.2021.803676. eCollection 2021.
8
Transcatheter embolization of hepatocellular carcinoma with epirubicin-loaded DC beads in Chinese patients.载表柔比星DC微球经导管肝动脉栓塞术治疗中国肝细胞癌患者
Transl Cancer Res. 2019 Feb;8(1):279-289. doi: 10.21037/tcr.2019.01.36.
9
Chronic pain severity, impact, and opioid use among patients with cancer: An analysis of biopsychosocial factors using the CHOIR learning health care system.癌症患者的慢性疼痛严重程度、影响和阿片类药物使用：利用 CHOIR 学习医疗保健系统分析心理社会因素。
Cancer. 2021 Sep 1;127(17):3254-3263. doi: 10.1002/cncr.33645. Epub 2021 Jun 1.
10
Clinical pain management by a multidisciplinary palliative care team: Experience from a tertiary cancer center in China.多学科姑息治疗团队的临床疼痛管理：来自中国一家三级癌症中心的经验。
Medicine (Baltimore). 2020 Nov 25;99(48):e23312. doi: 10.1097/MD.0000000000023312.
本文引用的文献
1
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.伴随 CYP2D6 抑制剂使用和他莫昔芬依从性对早期乳腺癌乳腺癌复发的影响。
J Clin Oncol. 2010 May 10;28(14):2423-9. doi: 10.1200/JCO.2009.25.0894. Epub 2010 Apr 12.
2
Opioid switching and rotation in primary care: implementation and clinical utility.基层医疗中的阿片类药物转换与轮换：实施与临床应用
Curr Med Res Opin. 2009 Sep;25(9):2133-50. doi: 10.1185/03007990903120158.
3
A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer.住院癌症患者中基于番泻苷的肠道准备方案使用与不使用多库酯的比较。
J Palliat Med. 2008 May;11(4):575-81. doi: 10.1089/jpm.2007.0178.
4
Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia.
J Opioid Manag. 2007 May-Jun;3(3):167-70. doi: 10.5055/jom.2007.0055.
5
A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients.一项关于皮质类固醇作为晚期癌症患者阿片类药物辅助药物的前瞻性随机研究。
Am J Hosp Palliat Care. 2007 Feb-Mar;24(1):13-9. doi: 10.1177/1049909106295431.
6
Modafinil: is it ready for prime time?莫达非尼：它准备好进入黄金时代了吗？
J Opioid Manag. 2006 May-Jun;2(3):130-6. doi: 10.5055/jom.2006.0022.
7
Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.丙氧芬（右丙氧芬）：对一种应尘封于历史的弱阿片类镇痛药的批判性综述。
Am J Ther. 2006 Nov-Dec;13(6):534-42. doi: 10.1097/01.mjt.0000253850.86480.fb.
8
Racial and ethnic disparities in pain management in the United States.美国疼痛管理中的种族和族裔差异。
J Nurs Scholarsh. 2006;38(3):225-33. doi: 10.1111/j.1547-5069.2006.00107.x.
9
Atypical antipsychotics in the management of delirium: a review of the empirical literature.非典型抗精神病药物在谵妄管理中的应用：实证文献综述
Palliat Support Care. 2005 Sep;3(3):227-37. doi: 10.1017/s1478951505050352.
10
Analgesic effect of gefitinib in the treatment of non-small cell lung cancer.
J Support Oncol. 2006 Mar;4(3):111.
Zotero 插件